EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
We are delighted to announce EORTC’s participation at the ESTRO Congress 2024 taking place from 3 to 7 May 2024 in Glasgow, UK. This year’s theme is Radiation Oncology: Bridging the Care Gap.
Save the date for the ESTRO-EORTC joint session on innovations in re-irradiation clinical trial design on Saturday 4 May 2024, from 08:45 to 10:00 AM.
In addition to the joint session, we are proud to showcase five abstracts on the topic of radiation oncology: three oral presentations and two digital posters. For a detailed overview, please consult the table below.
ESTRO-EORTC Joint Session
| Session | Scheduled on |
|---|---|
| ESTRO-EORTC – Innovations in re-irradiation clinical trial design Session Type: Interdisciplinary Session code: 1080 |
Saturday 04 May 08:45 – 10:00 GMT+1 Hall 2 |
EORTC Abstracts
| Abstract | Scheduled on |
|---|---|
| Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas among the European Organisation for Research and Treatment of Cancer (EORTC) Khaled Elsayad, Germany Session Type: Proffered Papers |
Saturday 04 May 10:30 – 11:30 GMT+1 Clyde |
| Interim results of the prospective RTQA procedures for HALT (CRUK/16/020, EORTC 1702-LCG-ROG) Daniel Portik, EORTC HQ Session Type: Proffered Papers |
Saturday 04 May 17:00 – 18:00 GMT+1 Hall 3 |
| Early Quality-of-Life after metastases-directed SBRT – results of the ESTRO & EORTC OligoCare cohort* Daniela Greto, Italy Session Type: Proffered paper |
Saturday 04 May 17:00 – 18:00 GMT+1 Hall 2 |
| Head-to-head comparison for breast RT planning: knowledge-based planning vs. deep learning solution Daniel Portik, EORTC HQ |
Digital Poster |
| A Trials within Cohorts comparing 1 fraction vs multiple-fraction SBRT in oligometastatic cancer* Piet Ost, Belgium |
Digital Poster |
*The Oligocare project is part of the E²-RADIatE platform. The E²-RADIatE platform and Oligocare project are supported by Walgreens Boots Alliance. OligoCare is also supported by Stiftung Bruckner.
Related News
EORTC participation at ISPOR Europe 2025 conference
7 Nov 2025
EORTC Quality of Life Group participating at the ISOQOL 2025 Conference
22 Oct 2025
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025
EORTC celebrates the 100th anniversary of p-value on World Statistics Day
20 Oct 2025
EORTC Announces Final Overall Survival Results from the PEACE-3 Trial
19 Oct 2025
Results from EORTC trial define new standard of care for aggressive brain tumours
18 Oct 2025
EORTC’s presence at ESMO 2025
17 Oct 2025
EORTC’s presence at EANO 2025
16 Oct 2025
EORTC celebrates Pink October: shaping the future of breast cancer care
15 Oct 2025
EORTC shines a light on advancements in radioligand therapy
8 Oct 2025
